Ingersoll Rand Inc. (IR) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and life science and industrial solutions. The company operates through two reportable segments: Industrial Technologies and Services and Precision and Science Technologies. The quarter was marked by significant M&A activity, including the acquisition of ILC Dover, and the divestiture of asbestos-related liabilities.
Key Financial Metrics
| Metric | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenues | $1,805.3 million | $1,686.5 million | $3,475.4 million | $3,315.8 million |
| Net Income (Attributable to IR) | $185.0 million | $179.5 million | $387.2 million | $340.6 million |
| Diluted EPS | $0.45 | $0.44 | $0.95 | $0.83 |
| Operating Income | $271.8 million | $272.4 million | $565.0 million | $512.7 million |
| Adjusted EBITDA | $494.6 million | $424.7 million | $953.1 million | $824.8 million |
| Free Cash Flow | $283.1 million | $203.6 million | $382.4 million | $351.5 million |
| Total Debt | $4,755.4 million | $2,723.6 million (Dec 2023) | N/A | |
| Cash & Equivalents | $1,062.5 million | $1,595.5 million (Dec 2023) | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Q2 2024 revenue increased 7.0% year-over-year, driven primarily by acquisitions ($117.0 million) and higher pricing ($42.3 million), partially offset by lower organic volumes and unfavorable foreign currency impacts.
- Profitability: Gross profit margin improved to 43.9% in Q2 2024 from 41.4% in Q2 2023, attributed to pricing and input cost productivity. Operating income remained flat year-over-year due to increased operating expenses.
- Debt Structure: Total debt increased significantly to $4.76 billion from $2.72 billion at year-end 2023. This reflects the issuance of $3.3 billion in new senior notes in May 2024 to fund the ILC Dover acquisition and refinance existing credit facilities.
- Unusual Items: "Other operating expense, net" increased to $88.2 million in Q2 2024 from $19.8 million in Q2 2023. This was primarily due to a $58.8 million pre-tax loss on the divestiture of asbestos liabilities and higher acquisition-related transaction costs.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted strong execution in pricing and cost productivity. The company continues to pursue M&A to expand its portfolio, evidenced by the ILC Dover acquisition which adds significant capabilities in biopharmaceutical and space industries. The company maintains a strong liquidity position with $2.6 billion of unused availability under its new revolving credit facility.
Risks and Contingencies:
- Asbestos Divestiture: The company successfully divested asbestos liabilities in June 2024, removing future exposure to these claims but incurring a one-time loss.
- Debt Service: Increased leverage and interest expense ($50.8 million in Q2) due to new debt issuances.
- Market Risks: Exposure to foreign currency fluctuations (approx. 53% of revenue in non-USD currencies) and potential volatility in raw material costs.
- Integration: Risks associated with integrating multiple acquisitions completed in the first half of 2024.
Investor Verification Checklist
- Asbestos Divestiture Impact: Verify the final accounting treatment of the $58.8 million loss and confirm the complete removal of asbestos liabilities from the balance sheet.
- Debt Covenants: Review compliance with the new leverage ratio covenant (max 3.50x, extendable to 4.00x) under the new revolving credit facility following the debt increase.
- Acquisition Integration: Monitor the integration progress and revenue contribution of the ILC Dover acquisition and other H1 2024 deals.
- Organic Volume Trends: Assess the sustainability of revenue growth given the reported decline in organic volumes in both segments.
- Interest Rate Exposure: Evaluate the impact of the new fixed-rate debt structure on future interest expense relative to the previous floating-rate mix.